DiaSorin is the embodiment of a tradition of growth and excellence focused on the improvement of human health. With more than 40 years of international experience, the DiaSorin Group develops, produces, and distributes immunoreagent kits for clinical diagnostics. Thanks to its well established expertise, specifically in the immunodiagnostics market, DiaSorin has become “the” in vitro diagnostics specialist. Over the years, by making available to the medical profession tests that can provide optimum guidance in making clinical decisions, DiaSorin has contributed to improving the delivery of health care and reducing its cost.
Fields Gina.Fields@DiaSorin.com Gina Fields Manager, Communications & Market Research at DiaSorin, Inc
Chen Even chen.even@DiaSorin.com Senior Corporate VP Commercial Operations
Carlo Rosa carlo.rosa@DiaSorin.com Chief Executive Officer
Gustavo Denegri - ? firstname.lastname@example.org Chairman
sem.LB.AE - pfcc in italy
paolo crivelli paolo.crivelli@DiaSorin.com Vice President Marketing / DiaSorin
Fran ois Gnemmi Fran.ois.Gnemmi@DiaSorin.com Senior Corporate Marketing Manager chez DiaSorin
lvm/sem.tc.a, gina, ems fpcf
For over 40 years the company has been developing, producing and marketing reagent kits for in vitro diagnostics worldwide. With their most recent acquisition of the NorDiag Group, DiaSorin gains access to the nucleic acid isolation and cell separation markets.
Its line of products used by diagnostic laboratories that are part of hospital facilities or operate independently (private diagnostic services laboratories) can meet the needs of the following clinical areas: infectious diseases, cardiac markers, bone metabolism, hepatitis and retrovirus, oncology and endocrinology.